Novartis AG (NOVNN) Q3 2021 Earnings Report

0 Followers

MX:NOVNN Q3 2021 EPS Results

Actual EPS: MXN 30.36
Consensus EPS: MXN 29.04
Beat/Miss: Beat by +MXN 1.31
One Year Ago EPS: MXN 26.99

MX:NOVNN Q3 2021 Revenue Results

Actual Revenue: MXN 274.25B
Expected Revenue: MXN 244.63B
Beat/Miss: Beat by +MXN 29.62B
YoY Revenue Growth: +6.10%

Earnings Announcement Details

Quarter: Q3 2021
Date: 10/26/2021
Time: Before Open
Conference Call: Tuesday, October 26, 2021

MX:NOVNN Upcoming Earnings

Novartis AG's next earnings date is estimated for February 3, 2027, based on past reporting schedules.

Q3 2021 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2021 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2021 Earnings Call Summary

No earnings call summary is available for this earnings event.

MX:NOVNN Earnings History

MX:NOVNN earnings history
Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Press Release
Feb 03, 2027	2026 (Q4)	42.12-	38.01	―	―
Oct 27, 2026	2026 (Q3)	42.5546.07	42.13	9.33% (+3.93)
Jul 21, 2026	2026 (Q2)	40.6045.13	45.32	-0.41% (-0.19)
Apr 28, 2026	2026 (Q1)	39.4037.27	42.7	-12.72% (-5.43)
Feb 04, 2026	2025 (Q4)	37.2538.01	37.08	2.53% (+0.94)
Oct 28, 2025	2025 (Q3)	42.5742.13	38.58	9.22% (+3.56)
Jul 17, 2025	2025 (Q2)	44.0345.32	36.89	22.84% (+8.43)
Apr 29, 2025	2025 (Q1)	39.5942.70	33.71	26.67% (+8.99)
Jan 31, 2025	2024 (Q4)	33.8037.08	28.65	29.41% (+8.43)
Oct 29, 2024	2024 (Q3)	36.2938.58	32.58	18.39% (+5.99)
Jul 18, 2024	2024 (Q2)	34.6436.89	32.47	13.61% (+4.42)
Apr 23, 2024	2024 (Q1)	31.4233.71	30.36	11.04% (+3.35)
Jan 31, 2024	2023 (Q4)	30.9228.65	26.99	6.18% (+1.67)
Oct 24, 2023	2023 (Q3)	31.2232.58	28.05	16.15% (+4.53)
Jul 18, 2023	2023 (Q2)	30.6932.47	27.7	17.24% (+4.78)
Apr 25, 2023	2023 (Q1)	27.1930.36	25.92	17.12% (+4.44)
Feb 01, 2023	2022 (Q4)	25.2126.99	24.85	8.59% (+2.13)
Oct 25, 2022	2022 (Q3)	27.5328.05	30.36	-7.59% (-2.30)
Jul 19, 2022	2022 (Q2)	26.7227.70	29.46	-5.98% (-1.76)
Apr 26, 2022	2022 (Q1)	25.7925.92	26.99	-3.96% (-1.07)
Feb 02, 2022	2021 (Q4)	25.1724.85	23.78	4.49% (+1.07)
Oct 26, 2021	2021 (Q3)	29.0430.36	26.99	12.49% (+3.37)
Jul 21, 2021	2021 (Q2)	27.6029.46	24.14	22.03% (+5.32)
Apr 27, 2021	2021 (Q1)	―26.99	27.7	-2.57% (-0.71)
Jan 26, 2021	2020 (Q4)	―23.78	23.43	1.52% (+0.36)
Oct 27, 2020	2020 (Q3)	―26.99	25.02	7.86% (+1.97)
Jul 21, 2020	2020 (Q2)	―24.14	23.78	1.50% (+0.36)
Apr 28, 2020	2020 (Q1)	―27.70	21.48	28.95% (+6.22)
Jan 29, 2020	2019 (Q4)	―23.43	19.61	19.48% (+3.82)
Oct 22, 2019	2019 (Q3)	―25.02	20.71	20.80% (+4.31)
Jul 18, 2019	2019 (Q2)	―25.09	21.35	17.54% (+3.75)
Apr 24, 2019	2019 (Q1)	―22.66	21.2	6.89% (+1.46)
Jan 30, 2019	2018 (Q4)	―20.69	20.04	3.27% (+0.66)
Oct 18, 2018	2018 (Q3)	―21.85	21.35	2.37% (+0.51)
Jul 18, 2018	2018 (Q2)	―21.35	20.19	5.75% (+1.16)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed

Novartis AG earnings date